Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The proposed study is a single center, double-blind placebo-controlled trial to assess the
safety and tolerability of the dapivirine ring as compared to a placebo ring when inserted
for 28 days in 16 healthy, HIV-negative women.